BioRem Inc. (CVE:BRM – Free Report) – Cormark decreased their FY2025 earnings per share (EPS) estimates for shares of BioRem in a research note issued to investors on Friday, May 30th. Cormark analyst N. Boychuk now forecasts that the company will earn $0.20 per share for the year, down from their prior forecast of $0.21.
BioRem Stock Performance
Shares of BRM opened at C$1.95 on Monday. The company’s 50 day simple moving average is C$2.03 and its 200-day simple moving average is C$2.56. The firm has a market cap of C$31.98 million, a PE ratio of 6.02 and a beta of 0.85. BioRem has a 12-month low of C$1.67 and a 12-month high of C$3.45. The company has a current ratio of 1.91, a quick ratio of 1.08 and a debt-to-equity ratio of 37.47.
BioRem Company Profile
BioRem Inc, a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs.
Featured Stories
- Five stocks we like better than BioRem
- ETF Screener: Uses and Step-by-Step Guide
- Apple’s Quiet HomePad Delay Could Be Its Loudest Move Yet
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- e.l.f. Gets Back on the Shelf! It’s Not Too Late to Buy In!
- Most active stocks: Dollar volume vs share volume
- Near 52-Week Lows, These 3 Mid-Cap Stocks Are Worth a Look
Receive News & Ratings for BioRem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRem and related companies with MarketBeat.com's FREE daily email newsletter.
